Subscribe
tetiana-yurchenko-shutterstock-com
Tetiana Yurchenko / Shutterstock.com
29 June 2015Americas

US court says ‘pay-for-delay’ settlements do not need to involve cash

The US Court of Appeals for the Third Circuit has ruled that so-called ‘pay-for-delay’ settlements do not need to involve cash payments to be considered anticompetitive.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
FTC demands corrections in GSK, Teva pay-for-delay ruling
17 March 2016   The US Federal Trade Commission has urged a federal appeals court to correct errors in a judgment from a Pennsylvania court that found the plaintiff in a pay-for-delay case had failed to prove that the agreement breached US competition law.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
FTC demands corrections in GSK, Teva pay-for-delay ruling
17 March 2016   The US Federal Trade Commission has urged a federal appeals court to correct errors in a judgment from a Pennsylvania court that found the plaintiff in a pay-for-delay case had failed to prove that the agreement breached US competition law.

More on this story

Americas
FTC demands corrections in GSK, Teva pay-for-delay ruling
17 March 2016   The US Federal Trade Commission has urged a federal appeals court to correct errors in a judgment from a Pennsylvania court that found the plaintiff in a pay-for-delay case had failed to prove that the agreement breached US competition law.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility